Prof. Dr. med. Thomas Wirth - Curriculum Vitae

Prof. Dr. med. Thomas Wirth is a senior physician and research group leader in the Clinical Department of Gastroenterology, Hepatology, Endocrinology at Hannover Medical School. After completing his preclinical medical studies in Greifswald, he moved to Hannover Medical School in 1999, where he graduated in 2004. He has worked as a junior physician since 2005, as a specialist in internal medicine and gastroenterology since 2015 and as a senior physician in the Clinical Department of Gastroenterology, Hepatology and Endocrinology since 2017.

In addition to his medical studies, Prof. Dr Wirth worked as a PhD student in Prof. Dr. med. Stefan Kubicka's working group from 1999 to 2005 and completed his doctorate in 2005 with the thesis "Cloning and characterization of a telomerase-dependent replicating adenovirus for the gene therapeutic treatment of tumors". In 2006, he moved to the University of Iowa for a research stay with a DFG research grant, where he worked for three years as a postdoctoral fellow in the research group of Prof. John T. Harty, Department of Microbiology. After returning to the Medical School, he founded his own research group in 2010 with a focus on T-cell immunology in infections and tumor diseases. Central to his research is the development of T-cell based cellular vaccines and the analysis of CD8 T-cell immune responses in infections and oncological diseases. In 2015, Prof. Dr. Wirth was awarded the Venia legendi for the subject "Experimental Gastroenterology". His work is supported by the German Research Foundation, German Cancer Aid and the Wilhelm Sander Foundation, among others. Prof. Dr. Wirth has published his research work in numerous original scientific papers.

Prof. Dr. Wirth has been a senior physician at the Gastro-oncology Day Clinic since 2017, where he cares for patients with gastrointestinal tumors and, in his capacity as director, deputy director, and principal investigator, is responsible for conducting national and international oncology studies. Since 2023, he has also served as director of the Center for Visceral Oncology at Hannover Medical School, and since 2025, as director of the ENETS Center Göttingen/Hannover for Neuroendocrine Tumors at the Hannover site.